8.02
-0.12
(-1.47%)
At close: January 24 at 5:35:27 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-18,670.00
-18,670.00
-12,605.00
-7,929.00
-5,843.00
Investing Cash Flow
-440.00
-440.00
-815.00
-238.00
-494.00
Financing Cash Flow
8,141.00
8,141.00
5,364.00
31,558.00
20,839.00
End Cash Position
24,280.00
24,280.00
35,247.00
43,304.00
19,913.00
Capital Expenditure
-1,093.00
-1,093.00
-662.00
-238.00
-316.00
Issuance of Capital Stock
12,592.00
12,592.00
102.00
32,435.00
17,953.00
Issuance of Debt
--
--
7,476.00
462.00
3,517.00
Repayment of Debt
-4,193.00
-4,193.00
-1,926.00
-947.00
-581.00
Repurchase of Capital Stock
-79.00
-79.00
-137.00
--
--
Free Cash Flow
-19,763.00
-19,763.00
-13,267.00
-8,167.00
-6,159.00
12/31/2020 - 7/21/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
0N6A.F TME Pharma N.V.
0.0675
-0.15%
ALTME.PA TME Pharma N.V.
0.0702
-1.40%
2511.HK HighTide Therapeutics, Inc.
1.110
0.00%
REVBW Revelation Biosciences, Inc.
0.0130
-9.72%
BPTSY Biophytis S.A.
3.0700
0.00%
ALBPS.PA Biophytis S.A.
0.3010
-2.27%
ALSEN.PA Sensorion SA
0.6220
-1.27%
SIGHT.PA GenSight Biologics S.A.
0.2845
+3.64%
ALCLS.PA Cellectis S.A.
1.5640
+1.56%
LADX LadRx Corporation
1.7000
0.00%